License and Collaboration Agreements (Details)
|
12 Months Ended |
|
|
|
|
|
Dec. 31, 2021
USD ($)
|
May 31, 2017
item
|
Feb. 28, 2017
USD ($)
|
Dec. 31, 2015
USD ($)
|
Feb. 28, 2015
USD ($)
|
| Monash License |
|
|
|
|
|
| License and Collaboration Agreements |
|
|
|
|
|
| Minimum annual fee |
$ 25,000
|
|
|
|
|
| Aggregate potential milestone payments |
$ 45,100,000
|
|
|
|
|
| Period of written notice to terminate |
30 days
|
|
|
|
|
| Monash License | Research and development |
|
|
|
|
|
| License and Collaboration Agreements |
|
|
|
|
|
| One-time cash payment |
$ 275,000
|
|
|
|
|
| Licensing Agreement | Scripps Research Institute |
|
|
|
|
|
| License and Collaboration Agreements |
|
|
|
|
|
| Minimum annual fee |
|
|
|
$ 25,000
|
|
| Aggregate potential milestone payments |
2,500,000
|
|
|
|
|
| Milestone payments made |
$ 0
|
|
|
|
|
| Period of written notice to terminate |
90 days
|
|
|
|
|
| Licensing Agreement | Scripps Research Institute | Research and development |
|
|
|
|
|
| License and Collaboration Agreements |
|
|
|
|
|
| One-time cash payment |
|
|
|
$ 10,000
|
|
| Licensing Agreement | Vernalis (R&D) Limited |
|
|
|
|
|
| License and Collaboration Agreements |
|
|
|
|
|
| Milestone payments made |
|
|
$ 3,000,000.0
|
|
|
| Period of written notice to terminate |
90 days
|
|
|
|
|
| Licensing Agreement | Vernalis (R&D) Limited | Minimum |
|
|
|
|
|
| License and Collaboration Agreements |
|
|
|
|
|
| Aggregate potential milestone payments |
$ 220,000,000
|
|
|
|
|
| Licensing Agreement | Vernalis (R&D) Limited | Research and development |
|
|
|
|
|
| License and Collaboration Agreements |
|
|
|
|
|
| One-time cash payment |
|
|
|
|
$ 1,000,000.0
|
| Clinical Trial Collaboration Agreement | Genentech |
|
|
|
|
|
| License and Collaboration Agreements |
|
|
|
|
|
| Number of patients enrollment completed | item |
|
16
|
|
|
|